Atlas Trials

Titration Study of ABX-1431

Clinical trial NCT03447756 · COMPLETED

Trial details

NCT number
NCT03447756
Sponsor
Abide Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Post Herpetic NeuralgiaDiabetic Peripheral NeuropathySmall Fiber NeuropathyPost-Traumatic Neuralgia
Start date
2017-10-02
Primary completion
2019-05-07
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.